Fennec Pharmaceuticals Statistics

Total Valuation

TSX:FRX has a market cap or net worth of CAD 311.17 million. The enterprise value is 306.63 million.

Market Cap	311.17M
Enterprise Value	306.63M

Important Dates

The next estimated earnings date is Friday, August 8, 2025.

Earnings Date	Aug 8, 2025
Ex-Dividend Date	n/a

Share Statistics

Current Share Class	27.62M
Shares Outstanding	n/a
Shares Change (YoY)	-1.05%
Shares Change (QoQ)	+0.43%
Owned by Insiders (%)	n/a
Owned by Institutions (%)	n/a
Float	14.38M

Valuation Ratios

PE Ratio	n/a
Forward PE	32.04
PS Ratio	7.00
PB Ratio	-36.82
P/TBV Ratio	n/a
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

EV / Earnings	-14.78
EV / Sales	7.26
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 5.13

Current Ratio	5.13
Quick Ratio	4.55
Debt / Equity	n/a
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	-3.23

Financial Efficiency

Return on Equity (ROE)	n/a
Return on Assets (ROA)	-12.96%
Return on Invested Capital (ROIC)	-31.30%
Return on Capital Employed (ROCE)	-31.51%
Revenue Per Employee	1.39M
Profits Per Employee	-648,514
Employee Count	32
Asset Turnover	0.53
Inventory Turnover	1.73

Taxes

In the past 12 months, TSX:FRX has paid 524,633 in taxes.

Income Tax	524,633
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has increased by +37.02% in the last 52 weeks. The beta is 0.40, so TSX:FRX's price volatility has been lower than the market average.

Beta (5Y)	0.40
52-Week Price Change	+37.02%
50-Day Moving Average	9.86
200-Day Moving Average	8.49
Relative Strength Index (RSI)	55.75
Average Volume (20 Days)	722

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	16.05

Income Statement

In the last 12 months, TSX:FRX had revenue of CAD 44.43 million and -20.75 million in losses. Loss per share was -0.76.

Revenue	44.43M
Gross Profit	40.11M
Operating Income	-17.22M
Pretax Income	-20.23M
Net Income	-20.75M
EBITDA	-16.74M
EBIT	-17.22M
Loss Per Share	-0.76

Full Income Statement

Balance Sheet

The company has 32.59 million in cash and 27.81 million in debt, giving a net cash position of 4.78 million.

Cash & Cash Equivalents	32.59M
Total Debt	27.81M
Net Cash	4.78M
Net Cash Per Share	n/a
Equity (Book Value)	-8.45M
Book Value Per Share	-0.31
Working Capital	49.74M

Full Balance Sheet

Cash Flow

Operating Cash Flow	-23.55M
Capital Expenditures	n/a
Free Cash Flow	n/a
FCF Per Share	n/a

Full Cash Flow Statement

Margins

Gross margin is 90.27%, with operating and profit margins of -38.76% and -46.71%.

Gross Margin	90.27%
Operating Margin	-38.76%
Pretax Margin	-45.53%
Profit Margin	-46.71%
EBITDA Margin	-37.68%
EBIT Margin	-38.76%
FCF Margin	n/a

Dividends & Yields

TSX:FRX does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	1.05%
Shareholder Yield	n/a
Earnings Yield	-6.67%
FCF Yield	n/a

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number	n/a
Graham Upside	n/a

Stock Splits

The last stock split was on September 5, 2014. It was a reverse split with a ratio of 0.3333333.

Last Split Date	Sep 5, 2014
Split Type	Reverse
Split Ratio	0.3333333

Scores

TSX:FRX has an Altman Z-Score of -3.95 and a Piotroski F-Score of 1. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score	-3.95
Piotroski F-Score	1